Search Results for "Torisel Protocols Research"
Original Source: CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors
This phase I trial is studying the side effects, best way to give, and best dose of CCI-779 and EKB-569 in treating patients with advanced solid tumors. Drugs used in chemotherapy, such as CCI-779, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. EKB-569 may stop the growth of tumor cells by blocking some of the enzymes needed for their growth. Giving CCI-779 together with EKB-569 may kill more tumor cells
Matching Channels
CombiCult® is an award winning, combinatorial screening technology that allows scientists to discover new and improved stem cell differentiation protocols. How Combicult® works A short o...
The emergence of antibiotic resistant microorganisms, lethal viruses and the threat of engineered microorganism have newly stimulated the interest in recombinant antibodies for infectious diseases. Ad...
Antibody-drug conjugates are designed to combine the specificity of antibodies directed against tumor-associated targets with potent cytotoxity. Upon internalization of the ADC, the antibody-bound c...
Clinical Approvals - news, views, reports and blogs
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and eff...
Matching News
Pfizer says Torisel-Avastin failed in cancer study
Pfizer said Friday that its drug Torisel failed to help patients with a form of advanced kidney cancer when combined with Roche's drug Avastin.The study compared renal cell carcinoma patients taking...
Pfizer's Torisel misses endpoint in second kidney cancer trial this year
Pfizer posted its second set of topline results this year for a failed clinical trial seeking to expand the approved label for the oncology drug Torisel (temsirolimus) in renal cell carcinoma (RCC),...
Pfizer says Torisel combo fails in Ph III for kidney cancer
In a second research disappointment within a matter of days, US drugs behemoth Pfizer (NYSE: PFE) revealed on Friday that the Phase III INTORACT trial (B1771006) evaluating its Torisel (temsirolimus)...
Pfizer's Torisel plus Avastin misses in first-line RCC
Pfizer Inc. (NYSE:PFE) said first-line treatment with IV Torisel temsirolimus plus Avastin bevacizumab missed the primary endpoint of improving progression-free survival (PFS) vs. Avastin plus interfe...
Pfizer's Torisel fails to hit targets in Avastin combo trial
Pfizer's Torisel fails to hit targets in Avastin combo trial
Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC
Pfizer Inc. announced today that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-...
Torisel-Avastin combo fails in kidney cancer
Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to a new Phase III trial investigating the two drugs as a fir...
Matching PubMed Articles
Variability in donation after cardiac death protocols: a national survey.
As donation after cardiac death practices expand, the number of institutional policies is increasing. We contacted organ procurement organizations throughout the United States and requested protocols...
Accuracy of NHANES Periodontal Examination Protocols.
This study evaluates the accuracy of periodontitis prevalence determined by the National Health and Nutrition Examination Survey (NHANES) partial-mouth periodontal examination protocols. True periodon...
Avulsion of permanent teeth: theory to practice.
Abstract - This paper presents clinical protocols for the emergency, early and post treatment complications of the avulsed tooth. The biological basis for these protocols is presented so that the...
In order to maximize the number of proteins identified from Hela S3 cell lysate we tested various cell lysis, protein precipitation and digestion protocols. First, we compared 3 different lysis buffer...
ABSTRACT: BACKGROUND: The foundations for ethylene research were laid many years ago by researchers such as Lizada, Yang and Hoffman. Nowadays, most of the methods developed by them are still being us...
